SOPH:NASDAQSOPHiA GENETICS SA Analysis

SOPHiA GENETICS SA is priced at $8.40 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 32.7%. Momentum indicators put RSI at 62.2 (approaching overbought) with MACD reading bearish. The recent range runs from support at $5.96 up to resistance at $8.98.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 16.1% above where the shares trade now. Revenue is growing at 27.2% on a -93.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 89.8%, a beta of 1.45 and a maximum drawdown of 25.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.